Additional practice-informing adverse event patterns and management in the KRYSTAL-1 Phase 2 study of adagrasib (MRTX849) in patients with KRASG12C-mutated NSCLC
Adagrasib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Additional practice-informing adverse event patterns and management in the KRYSTAL-1 Phase 2 study of adagrasib (MRTX849) in patients with KRASG12C-mutated NSCLC ### Output: Adagrasib